Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer

BACKGROUND: Pancreatic cancer is a rapidly fatal disease with gemcitabine remaining the first-line therapy. We performed a genotype–phenotype association study to identify biomarkers for predicting gemcitabine treatment outcome. MATERIALS AND METHODS: We selected the top 200 single nucleotide polymo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmacogenet Genomics
Hlavní autoři: Li, Liang, Zhang, Jian-Wei, Jenkins, Gregory, Xie, Fang, Carlson, Erin E., Fridley, Brooke L., Bamlet, William R., Petersen, Gloria M., McWilliams, Robert R., Wang, Liewei
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2016
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5083195/
https://ncbi.nlm.nih.gov/pubmed/27749787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000241
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky